Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 30, Number 10—October 2024
Research Letter
Spatiotemporal Epidemiology of Oropouche Fever, Brazil, 2015–2024
Suggested citation for this article
Abstract
We assessed the spatiotemporal dynamics of Oropouche fever in Brazil during 2015–2024. We found the number of cases substantially increased during that period, particularly in the Amazon region. Our findings underscore the need for improved surveillance and public health measures in response to the disease’s potential spread beyond endemic areas.
Oropouche fever is an emerging arboviral disease caused by Oropouche virus (OROV) and primarily transmitted by Culicoides paraensis biting midges. OROV is endemic to the Americas, predominantly the Amazon region of Brazil; estimates show ≈5 million persons live in areas at high risk for OROV transmission (1). Despite potential widespread transmission, Oropouche fever has been neglected, and limited data complicate implementation of effective disease control measures. In Brazil, OROV infection has caused numerous outbreaks, particularly in the Amazon region (2), where the climate and forest environment lead to vector proliferation. In 2024, the Pan American Health Organization and World Health Organization issued alerts of increased cases outside the Amazon (3) and possible vertical transmission events (4). Geographic spread affecting both rural areas and densely populated urban centers in non–Amazon region states underscores the virus’ adaptability to varied environments and highlights the urgent need for intensified surveillance and proactive prevention strategies. We assessed the spatiotemporal dynamics of Oropouche fever in Brazil during January 2015–March 2024.
We used anonymized data from the General Coordination of Arbovirus Surveillance of the Ministry of Health (protocol no. 25072.020334/2024-62) and included cases confirmed by reverse transcription PCR or enzyme immunoassay. We extracted information on sex, age, symptom onset, sample collection date, diagnostic method, and location of case notification. We mapped case distributions and calculated cumulative incidence rates per 100,000 inhabitants by using 2022 population census data. We identified high-risk clusters through retrospective spatiotemporal scanning by using SaTScan version 10.1.3 (https://www.satscan.org), QGIS version 3.36.3 (https://qgis.org), and the discrete Poisson model adjusted for population size. For temporal analysis, we used sample collection dates as reference points, given their enhanced precision and reliability within our dataset. We ran Monte Carlo simulations for significance testing and applied the annual percentage change technique by using Joinpoint Regression Program version 5.0.2 (https://surveillance.cancer.gov/joinpoint) to analyze disease incidence trends. We considered p<0.05 statistically significant in all analyses.
During January 2015–March 2024, Brazil recorded 5,407 Oropouche fever cases; 52% were among male and 48% among female persons. Most (71.4%) cases occurred among persons 20–59 years of age. In total, 18/27 (66.7%) states and 278/5,570 (5%) municipalities reported cases. Among notified cases, 97.1% (5,252 cases) occurred in the Amazon region; only 2.9% (155 cases) were reported outside that area (Appendix Table 1). Within the Amazon, Amazonas (82.4 cases/100,000 inhabitants), Rondônia (69 cases/100,000 inhabitants), and Acre (42.2 cases/100,000 inhabitants) states had the highest incidence rates. Among non–Amazon region states, Piauí (0.8 cases/100,000 inhabitants) and Bahia (0.7/100,000 inhabitants) had the highest rates (Figure 1, panel A).
Spatiotemporal analysis identified 4 major transmission clusters: one across Amazonas, Rondônia, Acre, Roraima, and Mato Grosso starting in 2023; another in Bahia in 2024; a third in Maranhão and Pará in 2021; and a fourth in Pará, Maranhão, and Piauí in 2018 (Figure 1, panel B; Appendix Table 2). Temporal analysis also revealed a statistically significant annual increase in incidence of 145.3% (95% CI 76.5%–240.7%) and a sudden rise in reported cases during December 2023–March 2024 (Figure 2).
The first limitation of this study is incomplete travel history data, which might have missed imported cases. Another limitation is potential underdiagnosis, which might have underestimated case numbers. Finally, possible residual or cross-protection immunity could have resulted in uncertainty regarding the at-risk population.
Oropouche fever is predominantly endemic to the Amazon region, where several factors create a favorable scenario for its persistence. The humid and warm climate, complemented by dense vegetation and frequent rainfall, provide ideal conditions proliferation of C. paraensis midges, the primary OROV vector. Concurrently, expansion of human activities, including deforestation and urbanization, modify that vector’s natural habitats, increasing transmission risks by reducing the spaces between humans and vectors (1,5,6). Moreover, increasing case numbers in non–Amazon region states might be linked to heightened human mobility and climate changes that extend the geographic distribution of vector habitats. That dynamic could be exacerbated by rapid urbanization without adequate infrastructure, enabling establishment of new urban transmission hotspots (7,8). In addition, potential novel OROV reassortment could enable adaptation to new vectors or enhance virulence, further contributing to expansion to previously unaffected areas (G.C. Scachetti et al., unpub. data, https://doi.org/10.1101/2024.07.27.24310296).
Oropouche fever has symptoms similar to other arboviruses, like dengue, which contributes to underreporting and complicates accurate diagnosis (9). Two Oropouche fever deaths were confirmed in state of Bahia, Brazil, on July 25, 2024 (https://www.cnnbrasil.com.br/nacional/segunda-morte-por-febre-oropouche-e-confirmada-na-bahia). Furthermore, recent reports from Pernambuco and Acre documented cases of vertical transmission, mirroring the complex epidemiologic challenges observed during the 2015–16 Zika virus outbreak (10).
In conclusion, the spatiotemporal dynamics of Oropouche fever in Brazil highlight critical aspects of its epidemiology, particularly its concentration within the Amazon region and statistically significant annual incidence rate increases. Considering the geographic expansion and potential vertical OROV transmission events flagged by the Pan American Health Organization and World Health Organization, this study underscores the pressing need for an integrated surveillance and response system that includes epidemiologic surveillance and public health strategies to effectively manage the expansion of Oropouche fever in Brazil.
Dr. Martins-Filho is an epidemiologist and the head of the Investigative Pathology Laboratory at the University Hospital, Federal University of Sergipe, and holds a research productivity fellowship with the National Council for Scientific and Technological Development (CNPq) in Brazil. His primary research focuses include epidemiology, clinical research, and evidence synthesis.
Acknowledgments
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
P.R.M.F. is a research productivity fellow at the at National Council for Scientific and Technological Development (CNPq), Brazil.
References
- Romero-Alvarez D, Escobar LE, Auguste AJ, Del Valle SY, Manore CA. Transmission risk of Oropouche fever across the Americas. Infect Dis Poverty. 2023;12:47. DOIPubMedGoogle Scholar
- Mourãão MP, Bastos MS, Gimaqu JB, Mota BR, Souza GS, Grimmer GHN, et al. Oropouche fever outbreak, Manaus, Brazil, 2007-2008. Emerg Infect Dis. 2009;15:2063–4. DOIPubMedGoogle Scholar
- Pan American Health Organization/World Health Organization. Epidemiological alert: Oropouche in the region of the Americas, 9 May 2024. Washington: The Organizations; 2024.
- Pan American Health Organization/World Health Organization. Epidemiological alert: Oropouche in the region of the Americas: vertical transmission event under investigation in Brazil, 17 July 2024. Washington: The Organizations; 2024.
- Moreira HM, Sgorlon G, Queiroz JAS, Roca TP, Ribeiro J, Teixeira KS, et al. Outbreak of Oropouche virus in frontier regions in western Amazon. Microbiol Spectr. 2024;12:
e0162923 . DOIPubMedGoogle Scholar - Sciancalepore S, Schneider MC, Kim J, Galan DI, Riviere-Cinnamond A. Presence and multi-species spatial distribution of Oropouche virus in Brazil within the One Health framework. Trop Med Infect Dis. 2022;7:111. DOIPubMedGoogle Scholar
- Fonseca LMDS, Carvalho RH, Bandeira AC, Sardi SI, Campos GS. Oropouche virus detection in febrile patients’ saliva and urine samples in Salvador, Bahia, Brazil. Jpn J Infect Dis. 2020;73:164–5. DOIPubMedGoogle Scholar
- Sah R, Srivastava S, Kumar S, Golmei P, Rahaman SA, Mehta R, et al. Oropouche fever outbreak in Brazil: an emerging concern in Latin America. Lancet Microbe. 2024;1:
100904 . DOIPubMedGoogle Scholar - Martins-Filho PR, Soares-Neto RF, de Oliveira-Júnior JM, Alves Dos Santos C. The underdiagnosed threat of oropouche fever amidst dengue epidemics in Brazil. Lancet Reg Health Am. 2024;32:
100718 . DOIPubMedGoogle Scholar - Martins-Filho PR, Carvalho TA, Dos Santos CA. Oropouche fever: reports of vertical transmission and deaths in Brazil. Lancet Infect Dis. 2024;
S1473-3099(24)00557-7 ; Epub ahead of print. DOIPubMedGoogle Scholar
Figures
Suggested citation for this article: Martins-Filho PR, Carvalho TA, dos Santos CA. Spatiotemporal epidemiology of Oropouche fever, Brazil, 2015–2024. Emerg Infect Dis. 2024 Oct [date cited]. https://doi.org/10.3201/eid3010.241088
Original Publication Date: August 30, 2024
Table of Contents – Volume 30, Number 10—October 2024
EID Search Options |
---|
|
|
|
Please use the form below to submit correspondence to the authors or contact them at the following address:
Paulo Ricardo Martins-Filho, Universidade Federal de Sergipe, Hospital Universitário, Laboratório de Patologia Investigativa, Rua Cláudio Batista, s/n. Sanatório. Aracaju, Sergipe 49060-100, Brazil
Top